Post-Marketing Surveillance to Evaluate the Safety and Efficacy of Picato Gel
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors LEO Pharma
- 29 Jan 2018 Status changed from active, no longer recruiting to completed.
- 04 Jan 2018 Planned End Date changed from 1 Dec 2019 to 1 Jan 2018.
- 04 Jan 2018 Planned primary completion date changed from 1 Dec 2019 to 1 Jan 2018.